CH5.L vs. KURE.L
CH5.L (Amundi ETF MSCI Europe Healthcare UCITS ETF) and KURE.L (KraneShares MSCI All China Health Care Index UCITS ETF USD) are both Health & Biotech Equities funds tracking the MSCI World/Health Care NR USD, from Amundi and MLC Management respectively. Both are passively managed. Over the past year, CH5.L returned 8.05% vs -10.03% for KURE.L. At a 0.23 correlation, their price movements are largely independent. CH5.L charges 0.25%/yr vs 0.65%/yr for KURE.L.
Performance
CH5.L vs. KURE.L - Performance Comparison
Loading charts...
Different Trading Currencies
CH5.L is traded in GBp, while KURE.L is traded in USD. To make them comparable, the KURE.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, CH5.L achieves a -3.01% return, which is significantly higher than KURE.L's -10.32% return.
CH5.L
- 1D
- 3.21%
- 1M
- 1.61%
- YTD
- -3.01%
- 6M
- -1.61%
- 1Y
- 8.05%
- 3Y*
- -26.49%
- 5Y*
- -13.43%
- 10Y*
- -3.17%
KURE.L
- 1D
- -2.53%
- 1M
- -11.57%
- YTD
- -10.32%
- 6M
- -20.07%
- 1Y
- -10.03%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CH5.L vs. KURE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CH5.L Amundi ETF MSCI Europe Healthcare UCITS ETF | -3.01% | 14.41% |
KURE.L KraneShares MSCI All China Health Care Index UCITS ETF USD | -10.32% | 11.24% |
Correlation
The correlation between CH5.L and KURE.L is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 29, 2025 | 0.23 |
CH5.L vs. KURE.L - Sectors Allocation Comparison
Sectors
CH5.L
KURE.L
Industrials
Healthcare
Financial Services
Technology
Consumer Cyclical
Basic Materials
Consumer Defensive
Energy
Utilities
Real Estate
Communication Services
Industrials
CH5.L
KURE.L
Healthcare
CH5.L
KURE.L
Financial Services
CH5.L
KURE.L
Technology
CH5.L
KURE.L
Consumer Cyclical
CH5.L
KURE.L
Basic Materials
CH5.L
KURE.L
Consumer Defensive
CH5.L
KURE.L
Energy
CH5.L
KURE.L
Utilities
CH5.L
KURE.L
Real Estate
CH5.L
KURE.L
Communication Services
CH5.L
KURE.L
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CH5.L vs. KURE.L — Risk / Return Rank
CH5.L
KURE.L
CH5.L vs. KURE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and KraneShares MSCI All China Health Care Index UCITS ETF USD (KURE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CH5.L | KURE.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.80 | ||
| Sortino ratioReturn per unit of downside risk | +1.09 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 0.97 | +0.13 |
| Calmar ratioReturn relative to maximum drawdown | 0.60 | -0.27 | +0.87 |
| Martin ratioReturn relative to average drawdown | 1.43 | -0.56 | +1.99 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CH5.L | KURE.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.49 | -0.31 | +0.80 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.42 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.13 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.02 | -0.01 | +0.03 |
Drawdowns
CH5.L vs. KURE.L - Drawdown Comparison
The maximum CH5.L drawdown since its inception was -70.04%, which is greater than KURE.L's maximum drawdown of -29.65%. Use the drawdown chart below to compare losses from any high point for CH5.L and KURE.L.
Loading charts...
Drawdown Indicators
| CH5.L | KURE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.04% | -29.65% | -40.39% |
Max Drawdown (1Y)Largest decline over 1 year | -13.44% | -29.65% | +16.21% |
Max Drawdown (3Y)Largest decline over 3 years | -70.04% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -70.04% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -70.04% | — | — |
Current DrawdownCurrent decline from peak | -64.16% | -29.65% | -34.51% |
Average DrawdownAverage peak-to-trough decline | -14.80% | -10.97% | -3.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.61% | 14.42% | -8.81% |
Volatility
CH5.L vs. KURE.L - Volatility Comparison
The current volatility for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) is 5.66%, while KraneShares MSCI All China Health Care Index UCITS ETF USD (KURE.L) has a volatility of 6.97%. This indicates that CH5.L experiences smaller price fluctuations and is considered to be less risky than KURE.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CH5.L | KURE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.66% | 6.97% | -1.31% |
Volatility (6M)Calculated over the trailing 6-month period | 11.79% | 17.88% | -6.09% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.28% | 26.43% | -10.15% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.85% | 26.09% | +5.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.28% | 26.09% | -0.81% |
CH5.L vs. KURE.L - Expense Ratio Comparison
CH5.L has a 0.25% expense ratio, which is lower than KURE.L's 0.65% expense ratio.
Dividends
CH5.L vs. KURE.L - Dividend Comparison
Neither CH5.L nor KURE.L has paid dividends to shareholders.
Frequently Asked Questions
CH5.L and KURE.L have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, CH5.L is cheaper at 0.25% per year. The better choice depends on whether you care most about return, fees, risk, or income.
CH5.L is cheaper with a 0.25% expense ratio, compared with 0.65% for KURE.L.
Both ETFs track MSCI World/Health Care NR USD. They also come from different issuers: Amundi and MLC Management. Their fees differ too: 0.25% for CH5.L and 0.65% for KURE.L.
Find the right allocation for CH5.L and KURE.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer